JP2001517931A5 - - Google Patents

Download PDF

Info

Publication number
JP2001517931A5
JP2001517931A5 JP1997540882A JP54088297A JP2001517931A5 JP 2001517931 A5 JP2001517931 A5 JP 2001517931A5 JP 1997540882 A JP1997540882 A JP 1997540882A JP 54088297 A JP54088297 A JP 54088297A JP 2001517931 A5 JP2001517931 A5 JP 2001517931A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997540882A
Other languages
English (en)
Japanese (ja)
Other versions
JP4219404B2 (ja
JP2001517931A (ja
Filing date
Publication date
Priority claimed from US08/757,541 external-priority patent/US5766877A/en
Application filed filed Critical
Publication of JP2001517931A publication Critical patent/JP2001517931A/ja
Publication of JP2001517931A5 publication Critical patent/JP2001517931A5/ja
Application granted granted Critical
Publication of JP4219404B2 publication Critical patent/JP4219404B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP54088297A 1996-05-10 1997-04-22 新規なアグーティ関連遺伝子 Expired - Fee Related JP4219404B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1750596P 1996-05-10 1996-05-10
US08/757,541 1996-11-27
US08/757,541 US5766877A (en) 1996-05-10 1996-11-27 Genes encoding art, an agouti-related transcript
US60/017,505 1996-11-27
PCT/US1997/006853 WO1997043412A1 (en) 1996-05-10 1997-04-22 Novel agouti-related gene

Publications (3)

Publication Number Publication Date
JP2001517931A JP2001517931A (ja) 2001-10-09
JP2001517931A5 true JP2001517931A5 (enExample) 2004-12-09
JP4219404B2 JP4219404B2 (ja) 2009-02-04

Family

ID=26689965

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54088297A Expired - Fee Related JP4219404B2 (ja) 1996-05-10 1997-04-22 新規なアグーティ関連遺伝子

Country Status (12)

Country Link
US (5) US5766877A (enExample)
EP (1) EP0917571B1 (enExample)
JP (1) JP4219404B2 (enExample)
AT (1) ATE283917T1 (enExample)
AU (1) AU2681497A (enExample)
CA (1) CA2253238C (enExample)
DE (1) DE69731834T2 (enExample)
DK (1) DK0917571T3 (enExample)
ES (1) ES2234015T3 (enExample)
PT (1) PT917571E (enExample)
SI (1) SI0917571T1 (enExample)
WO (1) WO1997043412A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843652A (en) * 1993-05-21 1998-12-01 Lockheed Martin Energy Systems, Inc. Isolation and characterization of Agouti: a diabetes/obesity related gene
US6310034B1 (en) 1993-05-21 2001-10-30 Ut-Battelle, Llc Agouti polypeptide compositions
US5766877A (en) * 1996-05-10 1998-06-16 Amgen Inc. Genes encoding art, an agouti-related transcript
WO1998020121A1 (en) * 1996-11-06 1998-05-14 Children's Medical Center Corporation Transgenic animal expressing a syndecan in the regions of hypothalamus
ES2288770T3 (es) * 1997-12-16 2008-01-16 MERCK & CO., INC. Region c-terminal de proteina de transcrito relacionado con aguti (art).
US6878520B1 (en) * 1997-12-16 2005-04-12 Merck & Co., Inc. C-terminal region of agouti-related transcript (ART) protein
AU3964499A (en) * 1998-03-30 1999-10-18 Gryphon Sciences Agouti-related protein analogs and methods of use
US6689873B1 (en) 1998-04-29 2004-02-10 Merck & Co., Inc. Nucleic acid encoding rat agouti related protein
EP1109830A4 (en) * 1998-09-03 2002-09-11 Millennium Pharm Inc MELANOCORTIN 4 RECEPTOR AS A TARGET FOR THE IDENTIFICATION OF COMPOUNDS USED TO TREAT NARCOMANIA
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
US6603058B1 (en) 1998-12-09 2003-08-05 Oklahoma Medical Research Foundation Non-human animal model for obesity and uses thereof
US6303749B1 (en) 1999-01-29 2001-10-16 Amgen Inc. Agouti and agouti-related peptide analogs
US20030064921A1 (en) * 1999-10-27 2003-04-03 The Regents Of The University Of California Methods and compounds for modulating melanocortin receptor ligand binding and activity
EP1125579A3 (en) 2000-01-18 2003-01-02 Pfizer Products Inc. Uses of agrp-melanocortin receptor binding modulating compounds
CN100369940C (zh) * 2000-05-31 2008-02-20 纳幕尔杜邦公司 烯烃聚合催化剂
AU2002238106A1 (en) * 2001-02-13 2002-08-28 Palatin Technologies, Inc. Melanocortin metallopeptides for treatment of sexual dysfunction
ES2278016T3 (es) 2001-04-09 2007-08-01 Novartis Vaccines And Diagnostics, Inc. Compuestos guanidino como agonistas del receptor de melanocortina 4 (mc4-r).
US20030207814A1 (en) * 2002-02-04 2003-11-06 Chiron Corporation Novel guanidinyl derivatives
US20030195187A1 (en) * 2002-02-04 2003-10-16 Chiron Corporation Guanidino compounds
US20050124652A1 (en) * 2002-02-04 2005-06-09 Rustum Boyce Guanidino compounds
AU2003219914A1 (en) * 2002-02-25 2003-09-09 Chiron Corporation Intranasal administration of mc4-r agonists
CA2486966A1 (en) * 2002-05-23 2003-12-04 Chiron Corporation Substituted quinazolinone compounds
EP1519650A4 (en) * 2002-07-03 2007-03-07 Merck & Co Inc AGOUTI-RELATED PROTEIN-DEFICIENT CELLS, NON-MENTAL TRANSGENIC ANIMALS, AND METHOD FOR SELECTION OF COMPOUNDS REGARDING THE CHANGING OF THE CHANGE OF ENERGY
US7625909B2 (en) * 2003-05-23 2009-12-01 Novartis Vaccines And Diagnostics, Inc. Substituted quinazolinone compounds
US20060173167A1 (en) * 2003-08-13 2006-08-03 Gunter Stempfer Process for the purification of recombinant polypeptides
MXPA06005736A (es) * 2003-11-19 2006-12-14 Chiron Corp Compuestos de quinazolinona con bioacumulacion reducida.
US6974187B2 (en) * 2004-01-28 2005-12-13 Tachi-S Co., Ltd. Vehicle seat structure
MXPA06012130A (es) * 2004-04-20 2007-01-31 Transtech Pharma Inc Derivados de tiazol y pirimidina substituidos como moduladores del receptor de melanocortina.
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
US7833927B2 (en) * 2005-08-31 2010-11-16 Rohm And Haas Company Single site palladium catalyst complexes
JP2012501334A (ja) * 2008-08-29 2012-01-19 トランス テック ファーマ，インコーポレイテッド 置換アミノチアゾール誘導体、医薬組成物、および使用の方法
CA2825098C (en) 2011-01-27 2020-03-10 Universite De Montreal Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
ATE12348T1 (de) * 1980-11-10 1985-04-15 Gersonde Klaus Prof Dr Verfahren zur herstellung von lipid-vesikeln durch ultraschallbehandlung, anwendung des verfahrens und vorrichtung zur durchfuehrung des verfahrens.
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
EP0088046B1 (de) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
US4615885A (en) * 1983-11-01 1986-10-07 Terumo Kabushiki Kaisha Pharmaceutical composition containing urokinase
EP0154316B1 (en) * 1984-03-06 1989-09-13 Takeda Chemical Industries, Ltd. Chemically modified lymphokine and production thereof
CA2006596C (en) * 1988-12-22 2000-09-05 Rika Ishikawa Chemically-modified g-csf
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5766877A (en) * 1996-05-10 1998-06-16 Amgen Inc. Genes encoding art, an agouti-related transcript

Similar Documents

Publication Publication Date Title
JP2001500295A5 (enExample)
JP2000502280A5 (enExample)
JP2000515496A5 (enExample)
JP2000501771A5 (enExample)
JP2000506264A5 (enExample)
JP2000501599A5 (enExample)
JP2001524936A5 (enExample)
JP2001525120A5 (enExample)
JP2001500134A5 (enExample)
JP2001509135A5 (enExample)
JP2000503342A5 (enExample)
JP2001501388A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000516489A5 (enExample)
JP2000502425A5 (enExample)
JP2000502485A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000509067A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2001517931A5 (enExample)
JP2000501744A5 (enExample)
JP2000504462A5 (enExample)